Guru Ownership Trend
Guru Analysis for Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $21.2 M.
Top institutional holders include Renaissance Technologies (RenTech) and Ken Fisher.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.58 M net outflow during the quarter.
Recent activity highlights Louis Moore Bacon who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 47.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Dyne Therapeutics, Inc. (DYN)
Major holders include Renaissance Technologies (RenTech) ($9.67 M), Ken Fisher ($5.86 M), Cliff Asness ($1.53 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.1 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.58 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited DYN. The total reported sell value was $7.72 M.
Yes, 1 managers opened new positions in DYN, and 3 increased their existing holdings. The total reported buy value was $4.14 M.